Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeru Imoto

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Breast Cancer Research and Treatment|August 21, 2020
Breast cancer survival among Japanese individuals and US residents of Japanese and other origins: a comparative registry-based studyRin Ogiya, Naoki Niikura, Hiraku Kumamaru, et al.
Breast Cancer (Tokyo, Japan)|January 23, 2023
Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1)Shigeru Imoto, Kun Wang, Xi-Wen Bi, et al.
European Journal of Breast Health|May 29, 2025
What Changes are Mandatory in Breast Surgery Training? An International Survey and Recommendations of the French Academy of Surgery and the Senologic International SocietyTolga Ozmen, Caroline Bouche, Megane Buttignol, et al.
Cancer Science|July 26, 2022
Establishment of a deep-learning system to diagnose BI-RADS4a or higher using breast ultrasound for clinical applicationTetsu Hayashida, Erina Odani, Masayuki Kikuchi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2022
Prognostic impact of postoperative radiotherapy in patients with breast cancer and with pT1-2 and 1-3 lymph node metastases: A retrospective cohort study based on the Japanese Breast Cancer RegistryAkimitsu Yamada, Naoki Hayashi, Hiraku Kumamaru, et al.
The Lancet. Oncology|January 2, 2021
Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trialMasakazu Toi, Shigeru Imoto, Takanori Ishida, et al.
British Journal of Cancer|January 18, 2024
Time-series blood cytokine profiles correlate with treatment responses in triple-negative breast cancer patientsDon Pietro Saldajeno, Shinpei Kawaoka, Norikazu Masuda, et al.
European Journal of Breast Health|July 20, 2022
The Senologic International Society Survey on Ductal Carcinoma <i>In Situ</i>: Present and FutureCarole Mathelin, Massimo Lodi, Khalid Alghamdi, et al.
European Journal of Breast Health|July 7, 2023
Current Challenges and Perspectives in Breast Cancer in Elderly Women: The Senologic International Society (SIS) SurveyLouise Scheer, Massimo Lodi, Tolga Özmen, et al.
Breast Cancer (Tokyo, Japan)|August 1, 2025
A retrospective multi-center cohort study investigating safety of sentinel lymph node biopsy for axillary staging in clinical T3-4c breast cancerSayaka Kuba, Yasuaki Sagara, Hiroshi Yano, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Breast Cancer Research and Treatment|August 21, 2020
Breast cancer survival among Japanese individuals and US residents of Japanese and other origins: a comparative registry-based studyRin Ogiya, Naoki Niikura, Hiraku Kumamaru, et al.
Breast Cancer (Tokyo, Japan)|January 23, 2023
Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1)Shigeru Imoto, Kun Wang, Xi-Wen Bi, et al.
European Journal of Breast Health|May 29, 2025
What Changes are Mandatory in Breast Surgery Training? An International Survey and Recommendations of the French Academy of Surgery and the Senologic International SocietyTolga Ozmen, Caroline Bouche, Megane Buttignol, et al.
Cancer Science|July 26, 2022
Establishment of a deep-learning system to diagnose BI-RADS4a or higher using breast ultrasound for clinical applicationTetsu Hayashida, Erina Odani, Masayuki Kikuchi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2022
Prognostic impact of postoperative radiotherapy in patients with breast cancer and with pT1-2 and 1-3 lymph node metastases: A retrospective cohort study based on the Japanese Breast Cancer RegistryAkimitsu Yamada, Naoki Hayashi, Hiraku Kumamaru, et al.
The Lancet. Oncology|January 2, 2021
Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trialMasakazu Toi, Shigeru Imoto, Takanori Ishida, et al.
British Journal of Cancer|January 18, 2024
Time-series blood cytokine profiles correlate with treatment responses in triple-negative breast cancer patientsDon Pietro Saldajeno, Shinpei Kawaoka, Norikazu Masuda, et al.
European Journal of Breast Health|July 20, 2022
The Senologic International Society Survey on Ductal Carcinoma <i>In Situ</i>: Present and FutureCarole Mathelin, Massimo Lodi, Khalid Alghamdi, et al.
European Journal of Breast Health|July 7, 2023
Current Challenges and Perspectives in Breast Cancer in Elderly Women: The Senologic International Society (SIS) SurveyLouise Scheer, Massimo Lodi, Tolga Özmen, et al.
Breast Cancer (Tokyo, Japan)|August 1, 2025
A retrospective multi-center cohort study investigating safety of sentinel lymph node biopsy for axillary staging in clinical T3-4c breast cancerSayaka Kuba, Yasuaki Sagara, Hiroshi Yano, et al.
Pageof 10